Premenstrual dysphoric disorder (PMDD) is a severe mood condition that comes and goes with the menstrual cycle. People with PMDD have symptoms that affect their mood, body and thinking. The symptoms follow the menstrual cycle and are severe enough to disrupt work, relationships and daily life. It is not “bad PMS”. It is a recognised psychiatric diagnosis, listed in DSM-5, the US manual of psychiatric diagnoses, since 2013, and in ICD-11, the World Health Organization’s classification of diseases, since 2019 [1].
How common it is depends heavily on how carefully it is diagnosed. A 2024 review of 44 studies found that when PMDD is confirmed properly, around 3.2% of people who menstruate have it; in community samples with confirmed diagnosis the figure is 1.6%, and studies relying on a single questionnaire suggest 7.7%, which the authors consider an overestimate [1]. The range is shown on this page rather than one number because the difference is about method, not about which study is right.
Proper diagnosis means daily symptom tracking across at least two menstrual cycles, since no blood or hormone test can confirm it [3]. That takes time, and someone has to suggest it in the first place.
1.6–7.7%
3.2%
72%
34%
Why it matters in Australia
No published national estimate was found of how many Australians live with PMDD, how long they wait for a diagnosis, or how many are treated. If the international estimates apply here, a large number of Australians are affected, but without local data that is an inference, not a measurement.
The stakes are high. In a survey of 599 people with confirmed PMDD, nearly three in four reported active suicidal thoughts at some point in their life, and about one in three reported a suicide attempt [2]. That study was an online survey of people already connected to PMDD support groups, so the true rates in the wider population are unknown, but the signal is strong enough that clinicians should ask about suicide risk.
Recognising PMDD in mental health care, general practice and gynaecology, and making daily symptom tracking a routine first step, are practical changes that do not depend on new research.
Global context
Formal recognition came slowly: PMDD became a full diagnosis in the US psychiatric manual, DSM-5, in 2013, and was added to the World Health Organization’s ICD-11 in 2019 [1]. Both steps matter because health systems and researchers use these classifications to define, count and study conditions.
Sources
- The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis (Reilly TJ et al.). Journal of Affective Disorders, 349, 2024.
- Lifetime prevalence of self-injurious thoughts and behaviors in 599 patients with prospectively confirmed premenstrual dysphoric disorder (Eisenlohr-Moul T et al.). BMC Psychiatry, 22, 2022.
- PMDs toolkit: track your symptoms. International Association for Premenstrual Disorders (IAPMD).
Last reviewed: